SCHEMBL5587630

SCHEMBL5587630

CCCCc1c(O)c(O)c(Cl)c(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.41
MAPK1 P28482 2/20 0.41
NPC1 O15118 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 3/20 0.38
TSHR P16473 3/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
FFAR1 O14842 1/20 0.37
TYMP P19971 2/20 0.36
CFTR P13569 4/20 0.36
CYP1A2 P05177 3/20 0.35
CYP2C9 P11712 3/20 0.35
HIF1A Q16665 2/20 0.35
KDM4E B2RXH2 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587173 0.94 ALOX5 (0.39) HPGDMAPK1NPC1HTTRAB9A
SCHEMBL5586732 0.93 HPGD (0.45) HPGDMAPK1NPC1HTTRAB9A
SCHEMBL5592667 0.92 ALOX5 (0.41) HSD17B10ALDH1A1LMNATYMPHIF1A
SCHEMBL5588597 0.92 ALOX5 (0.41) HSD17B10ALDH1A1LMNATYMPHIF1A
SCHEMBL5587783 0.92 ALOX5 (0.41) HSD17B10ALDH1A1LMNATYMPHIF1A
SCHEMBL5590103 0.92 ALOX5 (0.41) HSD17B10ALDH1A1LMNATYMPHIF1A
SCHEMBL5588251 0.92 ALOX5 (0.41) HSD17B10ALDH1A1LMNATYMPHIF1A
SCHEMBL5589634 0.91 HPGD (0.41) HPGDMAPK1NPC1HTTRAB9A
SCHEMBL5589567 0.89 HPGD (0.42) HPGDMAPK1NPC1HTTRAB9A
SCHEMBL5587663 0.87 HPGD (0.41) HPGDMAPK1NPC1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 HPGD 2689/4885MAPK1 2374/4885NPC1 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.